Vanke Overseas Investment Holding Company Limited

Income statement: notes and sources

Sources: S4 (FY2021–22), S3 (FY2023), S1 (FY2024–25). FY2022 other income includes the HK$38.4 M Ryder Court disposal gain. FY2023 other income includes the HK$13.7 M Regent Centre disposal gain. Basic and diluted EPS are identical because there are no dilutive instruments.

EBITDA and margins

EBITDA is not reported by the Company; all figures here are analyst calculations from S1, S3, S4. Underlying EBITDA excludes associate/JV results. Revenue CAGR FY2021–FY2025: +6.7% p.a. (461.2 to 596.7). This is flattered by one-off property sales: recurring revenue (rent, management fees, hotel and asset management) fell from HK$373.6 M to HK$302.4 M, a −5.1% CAGR.

Commentary. The five-year record has three phases. FY2021 was an outlier, with HK$424.6 M profit driven by non-recurring items: a Ryder Court revaluation of about HK$201 M and a ~HK$163 M share of a tenant termination fee at Mission. FY2022–FY2023 earnings collapsed to about HK$28 M a year. Recurring fees and rent were offset by US exposures — losses at Mission (HK$67.0 M share in FY2022, HK$130.4 M in FY2023) and Park Row impairments — with partial relief from the Hong Kong fee-rate uplift to 1.8% in 2023. FY2024–FY2025 brought losses as low-margin Bondlane I deliveries entered revenue. Contributing factors were a HK$72.0 M inventory provision (FY2024), continuing Mission losses until disposal, a HK$80.5 M Regent Centre revaluation loss (FY2025) and shrinking asset-management fees. H1 2026 marks an inflection: with Mission gone, no revaluation loss, a lower UNI drag and better Bondlane pricing, profit before tax was HK$37.3 M against a HK$91.1 M loss a year earlier.

Balance sheet

Sources: S4, S3, S1. No goodwill or intangible line appears in the consolidated statements. Book value per share is an analyst calculation (equity ÷ 389.53 M shares).

30 June 2026: cash HK$860.1 M; equity HK$4,060.2 M (book value per share HK$10.42); no bank borrowings; lease liabilities HK$12.3 M; a HK$77.9 M dividend payable, settled 9 July 2026; inventories HK$249.1 M; no contingent liabilities after release of the UNI guarantee.

Commentary. Total assets fell 28% between FY2021 and FY2025 as the Group exited the UK (Ryder Court), the US (Park Row, Mission) and the TW6 associate. It recycled capital into Hong Kong development and then into cash. Deleveraging was complete by FY2024: bank debt went from HK$1,207.6 M (FY2021) to nil. The FY2021 net current assets figure was depressed by HK$766.3 M of UK debt classified as current, which was repaid on the Ryder Court sale. The roughly HK$195 M decline in equity over five years reflects cumulative losses since 2024 plus dividends.

Cash flow

Sources: S1, S3, S4.

Operating cash flow, capex and free cash flow: The full cash flow statements are in the annual reports and were not captured in the announcements reviewed. An aggregator (etnet) reports FY2025 cash flow per share of HK$0.774, which implies FY2025 operating cash flow of roughly HK$301 M (S10; analyst calculation). This is consistent with Bondlane I sales converting inventory to cash (inventory fell by HK$240.9 M in FY2025). Capex was concentrated in The Stellar redevelopment in FY2021–FY2023: capital commitments fell from HK$280.1 M (FY2021) to HK$98.3 M (FY2022), HK$6.9 M (FY2023) and nil (FY2024–FY2025). There have been no buybacks in any year.

Ratios

Analyst calculations from S1, S3, S4.

• ROIC applies a 16.5% notional tax rate to EBIT (EBIT = PBT + finance costs − finance income).

• Negative net debt/EBITDA means net cash.

• FY2024–FY2025 interest coverage is not meaningful: EBIT was negative and finance costs consisted mainly of lease interest.

• The cash conversion cycle is not meaningful for this business model; receivables are mainly related-party fee balances.

• The Company's own reported debt-to-equity ratios match: 29.4% (FY2021), 15.3% (FY2022), 9.0% (FY2023), 0.7% (FY2024), 0.4% (FY2025).

Management guidance (H1 2026 interim, S2)

• Regent Centre and The Stellar are expected to maintain occupancy and pricing in H2 2026.

• Bondlane I handovers will continue to contribute revenue.

• Asset management will deliver "stable revenue and profit".

• No quantitative guidance is given.

Consensus expectations

None. There is no sell-side coverage.

Bull case

1. Cash-backed discount. At HK$1.72 the market value (about HK$670 M) is below post-dividend cash (about HK$782 M). Unencumbered real estate of about HK$2.8 bn (Regent Centre HK$1,874 M plus The Stellar within PP&E HK$906 M) and the JV receivable of HK$352 M are effectively valued at zero.

2. Earnings inflection. Removing Mission losses and UNI write-downs turned H1 2026 profit before tax from −HK$91.1 M to +HK$37.3 M. Further UNI completions and Bondlane sell-out could sustain profitability.

3. Capital-return capacity. The FY2025 DPS of HK$0.20 shows willingness to distribute cash. Released JV and inventory cash could support similar or special payouts.

Bear case

1. Parent-driven erosion. China Vanke's FY2025 RMB88.56 bn loss and dependence on Shenzhen Metro loans make continued shrinkage of VPHK invested capital — and of the fee line — likely. Asset-management revenue is already down 27% since FY2021.

2. Value trap. Minority shareholders cannot force asset monetisation. The controller may prefer to keep cash within the group, and the 0.16x P/B has persisted for years.

3. Run-off profile. Once Bondlane I and UNI Residence are complete, recurring revenue — rent, hotel and fees, about HK$300 M a year — faces structural decline. Industrial rents are falling and no new projects are planned.

Catalysts and monitorables (next 12 months)

Analyst verdict

Vanke Overseas is best understood as a balance sheet rather than an operating franchise. Five years of disposals and deleveraging have left a company with no bank debt and HK$860 M cash at mid-2026. Its balance sheet also holds roughly HK$2.8 bn of unencumbered Hong Kong real estate and a de-risked tail of residential development. Against that, the equity is valued at about HK$0.67 bn. On almost any asset-based metric — price-to-book near 0.16x, negative enterprise value, a trailing dividend yield above 11% — the shares look mispriced.

The discount is not irrational, however. Recurring earning power is modest and eroding. Asset-management fees, a quarter to a third of revenue and the Group's most scalable line, depend entirely on a parent that lost RMB88.56 bn in 2025 and is shrinking its overseas capital. Regent Centre is an ageing industrial asset with falling rents, and The Stellar earns single-digit margins. Most importantly, minority holders own 25% of a controlled company with no stated growth plan. Value realisation therefore depends on decisions made in Shenzhen, not Central.

The H1 2026 swing to profit is genuine but largely subtractive: losses stopped, rather than new earnings arriving. Sustained profitability now hinges on UNI Residence completion, the residual Bondlane sales and the pace of fee attrition. The FY2025 HK$0.20 dividend is the strongest signal that cash will be shared, and its repetition in March 2027 is the key test.

Verdict: Asset-rich, earnings-poor, governance-contingent. A re-rating most plausibly requires a corporate action — a stake sale, privatisation, asset monetisation or special distribution — rather than organic improvement. Rating stance (analyst view, not investment advice): Deep Value / Special Situation — Hold with event-driven upside.

All figures are from public filings and data sources listed in the source key. Analyst calculations are labelled as such.